Australian cancer specialist Richard Scolyer dies at 59 after pioneering treatment
Renowned Australian cancer specialist Richard Scolyer has passed away at age 59 after battling glioblastoma. Scolyer, a pioneer in melanoma immunotherapy, famously used his own terminal diagnosis to test experimental treatments that may offer future breakthroughs for brain cancer patients.
Why it matters
His work and personal sacrifice have significantly advanced immunotherapy research, potentially changing the prognosis for aggressive brain tumors globally.
WELLINGTON, June 8 (Reuters) – Richard Scolyer, the Australian cancer specialist who became a test case for an experimental treatment after being diagnosed with an aggressive brain tumour, has died aged 59, prompting tributes to a researcher whose work helped transform melanoma care.
The article is a factual obituary reporting on the life and contributions of a public figure without political slant.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in